Page last updated: 2024-08-24

dexmedetomidine and Lung Adenocarcinoma

dexmedetomidine has been researched along with Lung Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gao, H; Hu, C; Qian, Y; Wang, Y; Xu, B; Yang, J	1

Other Studies

1 other study(ies) available for dexmedetomidine and Lung Adenocarcinoma

Article	Year
Dexmedetomidine upregulates the expression of miR-493-5p, inhibiting growth and inducing the apoptosis of lung adenocarcinoma cells by targeting RASL11B. Biochemistry and cell biology = Biochimie et biologie cellulaire, 2021, Volume: 99, Issue:4 Topics: Adenocarcinoma of Lung; Adrenergic alpha-2 Receptor Agonists; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Dexmedetomidine; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MicroRNAs; Monomeric GTP-Binding Proteins; Tumor Cells, Cultured	2021

Article

Year

Dexmedetomidine upregulates the expression of miR-493-5p, inhibiting growth and inducing the apoptosis of lung adenocarcinoma cells by targeting RASL11B.

Biochemistry and cell biology = Biochimie et biologie cellulaire, 2021, Volume: 99, Issue:4

Topics: Adenocarcinoma of Lung; Adrenergic alpha-2 Receptor Agonists; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Dexmedetomidine; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MicroRNAs; Monomeric GTP-Binding Proteins; Tumor Cells, Cultured

2021